Secondary Response to Chronic Respiratory Acidosis in Humans: A Prospective Study

人类慢性呼吸性酸中毒的继发性反应:一项前瞻性研究

阅读:3

Abstract

INTRODUCTION: The magnitude of the secondary response to chronic respiratory acidosis, that is, change in plasma bicarbonate concentration ([HCO(3)(-)]) per mm Hg change in arterial carbon dioxide tension (PaCO(2)), remains uncertain. Retrospective observations yielded Δ[HCO(3)(-)]/ΔPaCO(2) slopes of 0.35 to 0.51 mEq/l per mm Hg, but all studies have methodologic flaws. METHODS: We studied prospectively 28 stable outpatients with steady-state chronic hypercapnia. Patients did not have other disorders and were not taking medications that could affect acid-base status. We obtained 2 measurements of arterial blood gases and plasma chemistries within a 10-day period. RESULTS: Steady-state PaCO(2) ranged from 44.2 to 68.8 mm Hg. For the entire cohort, mean (± SD) steady-state plasma acid-base values were as follows: PaCO(2), 52.8 ± 6.0 mm Hg; [HCO(3)(-)], 29.9 ± 3.0 mEq/l, and pH, 7.37 ± 0.02. Least-squares regression for steady-state [HCO(3)(-)] versus PaCO(2) had a slope of 0.476 mEq/l per mm Hg (95% CI = 0.414-0.538, P < 0.01; r = 0.95) and that for steady-state pH versus PaCO(2) had a slope of -0.0012 units per mm Hg (95% CI = -0.0021 to -0.0003, P = 0.01; r = -0.47). These data allowed estimation of the 95% prediction intervals for plasma [HCO(3)(-)] and pH at different levels of PaCO(2) applicable to patients with steady-state chronic hypercapnia. CONCLUSION: In steady-state chronic hypercapnia up to 70 mm Hg, the Δ[HCO(3)(-)]/ΔPaCO(2) slope equaled 0.48 mEq/l per mm Hg, sufficient to maintain systemic acidity between the mid-normal range and mild acidemia. The estimated 95% prediction intervals enable differentiation between simple chronic respiratory acidosis and hypercapnia coexisting with additional acid-base disorders.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。